Breast Cancer
Advertisement
Sacituzumab govitecan is associated with better QoL benefit than TPC in patients with HR+/HER2− BC.
An exploratory study focused on understanding dietary patterns and adherence to recommended nutritional guidelines.
Researchers explored the relationship between post-traumatic growth and perceived stress in this population of patients.
Less than half of patients with cancer had caregivers who spoke for more than 4% of a clinical encounter.
Learn how a personalized 12-week exercise program can enhance quality of life outcomes in survivors of breast cancer.
Empowerment-Based Nursing Intervention Improved Patient Outlook After Breast Cancer Brain Metastases
Researchers analyzed if the intervention could improve negative emotions, quality of life, and satisfaction with nursing. 
A new study highlights the effectiveness of a nurse navigation program for patients undergoing treatment for these cancers.
Researchers aimed to identify the best timing for telenursing follow-up after chemotherapy.
There are several important nursing considerations to keep in mind when evaluating a patient’s risk for breast cancer.
Panelists discuss data from the ADEPT trial, port considerations, and their hopes for the future of breast cancer therapy.
Panelists discuss how nurses can maximize opportunities for connection as they treat patients with breast cancer.
The panelists discuss clinical trial data and patient preferences surrounding subcutaneous versus IV administration routes.
Panelists discuss how subcutaneous treatments can mitigate time toxicity and improve quality of life.
Panelists discuss how treatment options have changed and if indefinite therapy is still needed for certain patients.
Panelists discuss how to help patients understand the diagnosis and navigate treatment options.
Learn how oncology nurses can be leaders in building oncofertility conversations and programs.
A new study builds upon previous research addressing complex questions surrounding pregnancy after breast cancer.
In this video, Dr. Polyak speaks about what the lectureship means to her at SABCS 2023.
In this video interview, Dr. Welm speaks about what the award means to her and her hopes for the future.
There are critical time intervals for starting systemic therapy in patients with early triple-negative breast cancer.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.